Targeting cancer stem cells in myelodysplastic syndrome
Project/Area Number |
23591392
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Hematology
|
Research Institution | Kyushu University |
Principal Investigator |
|
Project Period (FY) |
2011 – 2013
|
Project Status |
Completed (Fiscal Year 2013)
|
Budget Amount *help |
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2013: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2012: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2011: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Keywords | 骨髄異形成症候群 / がん幹細胞 / 免疫不全マウス / 異種移植アッセイ / SIRPA / 幹細胞 / 異種移植モデル |
Research Abstract |
Cancer stem cells (CSCs) are therapeutic targets and must be eliminated to cure the patients. However, those cells have not been found yet in myelodysplastic syndrome (MDS). Immunodeficient mice are widely used to reconstitute human hematopoiesis by xenotransplantation of hematopoietic stem cells (HSCs), and this model provides a powerful tool to evaluate biological properties of human cancer stem cells. We found that in xenograft rejection, the innate phagocytic reaction of mouse macrophages could occur because murine SIRPA (mSIRPA) on macrophages cannot bind to human CD47 (hCD47). Thus, introduction of human SIRPA allows mouse macrophage to bind hCD47 on the graft, resulting in inhibition of phagocytic reaction against human cells. Here, we have established a new immunodeficient mouse line, B6-Rag2(null)Il2rg(null) mice with human SIRPA to induce complete macrophage tolerance.This strain should be very useful in xenotransplant experiments to assay MDS stem cells.
|
Report
(4 results)
Research Products
(33 results)
-
-
[Journal Article] The BALB/c-specific polymorphic SIRPA enhances its affinity for human CD47, inhibiting phagocytosis against human cells to promote xenogeneic engraftment.2014
Author(s)
Iwamoto C, Takenaka K, Urata S, Yamauchi T, Shima T, Kuriyama T, Daitoku S, Saito Y, Miyamoto T, Iwasaki H, Kitabayashi I, Itoh K, Kishimoto J, Kohda D, Matozaki T, Akashi K.
-
Journal Title
Exp Hematol
Volume: 42
Pages: 163-171
Related Report
Peer Reviewed
-
-
-
-
[Journal Article] Polymorphic Sirpa is the genetic determinant for NOD-based mouse lines to achieve efficient human cell engraftment.2013
Author(s)
Yamauchi T, Takenaka K, Urata S, Shima T, Kikushige Y, Tokuyama T, Iwamoto C, Nishihara M, Iwasaki H, Miyamoto T, Honma N, Nakao M, Matozaki T, Akashi K.
-
Journal Title
Blood
Volume: 121
Pages: 1316-25
NAID
Related Report
Peer Reviewed
-
[Journal Article] Quantitation of hematogones at the time of engraftment is a useful prognostic indicator in allogeneic hematopoietic stem cell transplantation.2013
Author(s)
Shima T, Miyamoto T, Kikushige Y, Mori Y, Kamezaki K, Takase K, Henzan H, Numata A, Ito Y, Takenaka K, Iwasaki H, Kamimura T, Eto T, Nagafuji K, Teshima T, Kato K, Akashi K.
-
Journal Title
Blood
Volume: 121
Pages: 840-8
Related Report
Peer Reviewed
-
[Journal Article] Contribution of bone marrow-derived hematopoietic stem/progenitor cells to the generation of donor-marker⁺ cardiomyocytes in vivo.2013
Author(s)
Fukata M, Ishikawa F, Najima Y, Yamauchi T, Saito Y, Takenaka K, Miyawaki K, Shimazu H, Shimoda K, Kanemaru T, Nakamura K, Odashiro K, Nagafuji K, Harada M, Akashi K.
-
Journal Title
Related Report
Peer Reviewed
-
[Journal Article] Quantitation of hematogones at the time of engraftment is a useful prognostic indicator in allogeneic hematopoietic stem cell transplantation.2013
Author(s)
Shima T, Miyamoto T, Kikushige Y, Mori Y, Kamezaki K, Takase K, Henzan H, Numata A, Ito Y, Takenaka K, Iwasaki H, Kamimura T, Eto T, Nagafuji K, Teshima T, Kato K, Akashi K
-
Journal Title
Blood
Volume: 121
Pages: 840-848
Related Report
Peer Reviewed
-
[Journal Article] Polymorphic Sirpa is the genetic determinant for NOD-based mouse lines to achieve efficient human cell engraftment.2013
Author(s)
Yamauchi T, Takenaka K, Urata S, Shima T, Kikushige Y, Tokuyama T, Iwamoto C, Nishihara M, Iwasaki H, Miyamoto T, Honma N, Nakao M, Matozaki T, Akashi K
-
Journal Title
Blood
Volume: 121
Pages: 1316-1325
NAID
Related Report
Peer Reviewed
-
-
-
[Journal Article] Engulfment of hematopoietic stem cells caused by down-regulation of CD47 is critical in the pathogenesis of hemophagocytic lymphohistiocytosis.2012
Author(s)
Kuriyama T, Takenaka K, Kohno K, Yamauchi T, Daitoku S, Yoshimoto G, Kikushige Y, Kishimoto J, Abe Y, Harada N, Miyamoto T, Iwasaki H, Teshima T, Akashi K
-
Journal Title
Blood
Volume: 120
Pages: 4058-4067
Related Report
Peer Reviewed
-
-
-
[Journal Article] Initial low-dose valganciclovir as a preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients.2012
Author(s)
Takenaka K, Nagafuji K, Takase K, Kamimura T, Mori Y, Ito Y, Nishi Y, Henzan H, Kato K, Harada N, Eto T, Miyamoto T, Teshima T, Akashi K.
-
Journal Title
Int J Hematol
Volume: 96
Pages: 94-100
NAID
Related Report
Peer Reviewed
-
-
-
[Journal Article] Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia2011
Author(s)
Kikushige Y, Ishikawa F, Miyamoto T, Shima T, Urata S, Yoshimoto G, Mori Y, Iino T, Yamauchi T, Eto T, Niiro H, Iwasaki H, Takenaka K, Akashi K
-
Journal Title
Cancer Cell
Volume: 20
Pages: 246-259
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-
-
-
-